Star Portfolios
Nippon Life India Trustee Ltd- A/C Nippon India Pha
Institution · data to Jun 2026
Disclosed value
₹829 Cr
Jun 2026 closes
At current prices
…
Current holdings
2
Tracked since
Sep 2022
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
+0.35pp₹722 Cr
0.00pp₹107 Cr
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Medplus Health Services Ltd | 7.32% | 0.35 | ₹722 Cr |
| Suraksha Diagnostic Ltd | 7.48% | flat | ₹107 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, Nippon Life India Trustee Ltd- A/C Nippon India Pha — an institution tracked through public shareholding filings — disclosed 2 holdings in Indian listed companies worth ₹829 crore. The same holdings-at-filing-value basis put it at ₹95 crore in Mar 2026 (+768.6%). Solomo carries these filings back to Sep 2022.
Largest disclosed positions in Jun 2026: Medplus Health Services Ltd (MEDPLUS — 7.32% of the company, ₹722 crore); Suraksha Diagnostic Ltd (SURAKSHA — 7.48% of the company, ₹107 crore).
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹829 Cr | +768.6% |
| Mar 2026 | ₹95 Cr | −96.7% |
| Dec 2025 | ₹2,915 Cr | −5.5% |
| Sep 2025 | ₹3,085 Cr | +19.2% |
| Jun 2025 | ₹2,588 Cr | +155% |
| Mar 2025 | ₹1,015 Cr | −53.7% |
| Dec 2024 | ₹2,192 Cr | +433.1% |
| Sep 2024 | ₹411 Cr | −70% |
All star portfolios 9 further positions appear in earlier filings but not in Jun 2026.Quarterly shareholding filings (BSE/NSE); only stakes above the 1% disclosure threshold are public. Not investment advice.